Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
208
-
Total 13F shares, excl. options
-
81.1M
-
Shares change
-
+721K
-
Total reported value, excl. options
-
$1.83B
-
Value change
-
+$18.3M
-
Put/Call ratio
-
0.72
-
Number of buys
-
96
-
Number of sells
-
-99
-
Price
-
$22.52
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q1 2022
247 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q1 2022.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 208 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 81.1M shares
of 106M outstanding shares and own 76.58% of the company stock.
Largest 10 shareholders include BlackRock Inc. (15.4M shares), VANGUARD GROUP INC (10.4M shares), RENAISSANCE TECHNOLOGIES LLC (7.77M shares), INGALLS & SNYDER LLC (6.91M shares), FEDERATED HERMES, INC. (4.74M shares), STATE STREET CORP (3.41M shares), Parallel Advisors, LLC (1.94M shares), DIMENSIONAL FUND ADVISORS LP (1.94M shares), MILLENNIUM MANAGEMENT LLC (1.77M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.67M shares).
This table shows the top 208 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.